LianBio Annual Operating Income (Loss) in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
LianBio quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2022.
  • LianBio Operating Income (Loss) for the quarter ending September 30, 2023 was -$26.3M, a 7.14% decline year-over-year.
  • LianBio Operating Income (Loss) for the twelve months ending September 30, 2023 was -$107M, a 9.81% increase year-over-year.
  • LianBio annual Operating Income (Loss) for 2022 was -$125M, a 35.9% increase from 2021.
  • LianBio annual Operating Income (Loss) for 2021 was -$196M, a 45% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$125M +$70.2M +35.9% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-28
2021 -$196M -$60.7M -45% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$135M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.